3mensio Announces FDA Clearance of 3surgery Vascular Imaging Software
25 February 2008
3mensio Medical Imaging BV recently announced that the company has received US Food and Drug Administration (FDA) clearance to market 3surgery™ Vascular Imaging (VI) software.
This software provides a clinical application for vascular surgeons using CTA or MRA studies to determine abnormalities of the vessels within thorax or abdomen, both in 2D and 3D.
3surgery VI provides valuable tools for stent and graft planning of endovascular procedures.
ABOUT THE 3SURGERY SOFTWARE
Imaging has become crucial within the field of surgery in the process of diagnosis and pre-operative procedures. New promising techniques like Endo Vascular Aneurysm Repair (EVAR) rely completely on an accurate diagnosis and measurements using solely 2D and 3D images from the radiology department.
3surgery Vascular imaging software provides these accurate tools for the pre and post operative planning of your procedures on any PC.
"This software basically allows me to see a patient in my office, determine if they’re a candidate for stent graph, and size the device and conduct preoperative planning with the patient right beside me. It typically takes less than 15 minutes," says Dr Bart Muhs, Co-Director of the Endovascular Program at Yale University School of Medicine.
"This is appreciated by both myself and the patients who are sitting there; they feel like they’re participating in their care," Dr Muhs concludes.
